研究SOS1介导的KRAS激活机制的早期结构变化
Kirti Bhadhadhara1, Vinod Jani1, Shruti Koulgi1
1High Performance Computing-Medical & Bioinformatics Applications Group, Centre for Development of Advanced Computing (C-DAC), Innovation Park, Panchawati, Pashan, Pune, 411008, India.
Current research in structural biology
|January 8, 2024
概括
这项研究使用了分子动力学模拟来探索"无七之子1" (SOS1) 如何激活KRAS. 研究结果显示,特定的KRAS结合的核酸和全位的结构变化影响了KRAS激活通路,指导了抑制剂的发展.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 计算生物学是一种计算生物学.
背景情况:
- 克拉斯激活是由无七之子1 (SOS1) 的SOS1调节的,它是一种关氨酸核酸交换因子.
- SOS1在KRAS上促进了GDP到GTP的交换,这是蜂信号传输的关键步骤.
- 了解SOS1对KRAS激活的全质调节对于向治疗至关重要.
研究的目的:
- 通过分子动力学模拟来研究SOS1介导的KRAS激活的机制.
- 分析不同KRAS结合核酸 (GDP/GTP) 在全和催化位点对KRAS激活的影响.
- 确定SOS1-KRAS相互作用中涉及的关键残留物和构造变化.
主要方法:
- 在九个KRAS-SOS1-KRAS复合体上进行了分子动力学模拟.
- 分析了各种形状和热力学参数.
- 使用MMPBSA自由能量分析来评估绑定亲和关系.
主要成果:
- 与GTP结合的KRAS相比,与GDP结合的KRAS在SOS1 CDC25位点的结合亲和力明显较低.
- 在SOS1 REM部位结合的KRAS影响了在CDC25部位的KRAS中与激活相关的变化.
- 确定了特定的SOS1残留物 (R694,S732,K735,S807,W809,K814),这些残留物对KRAS相互作用和激活至关重要.
结论:
- 通过SOS1的体调制通过不同的途径 (缓慢/快速/罕见) 影响KRAS激活.
- 在REM部位的KRAS开关区域 (I,II,β2) 的形态变化对全激活至关重要.
- 对结合亲缘关系,相互作用残留物和动态的洞察力可以为针对SOS1-介导的KRAS激活的抑制剂的开发提供信息.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K


